CAPILLARY

Capillary Technologies India Share Price

 

Stock touched all time low

 

Invest in Capillary Technologies India with 2.59X leverage

Invest with MTF

Performance

  • Low
  • ₹536
  • High
  • ₹556
  • 52 Week Low
  • ₹536
  • 52 Week High
  • ₹799
  • Open Price₹552
  • Previous Close₹562
  • Volume91,014
  • 50 DMA₹641.29
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -14.14%
  • Over 3 Month -6.72%
  • Over 6 Month -6.72%
  • Over 1 Year -6.72%

Smart Investing Starts Here Start SIP with Capillary Technologies India for Steady Growth!

Invest Now

Capillary Technologies India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 4,253
  • P/B Ratio
  • 7.5
  • Average True Range
  • 26.21
  • EPS
  • 2.78
  • Dividend Yield
  • 0
  • MACD Signal
  • -14.75
  • RSI
  • 31.63
  • MFI
  • 20.53

Capillary Technologies India Financials

Capillary Technologies India Technicals

EMA & SMA

Current Price
₹536.20
-25.95 (-4.62%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 0
  • 20 Day
  • ₹609.62
  • 50 Day
  • ₹641.29
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

564.15 Pivot Speed
  • R3 592.70
  • R2 583.85
  • R1 573.00
  • S1 553.30
  • S2 544.45
  • S3 533.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Capillary Technologies provides an AI-enabled, cloud-native SaaS loyalty management platform used by brands across 46 countries. It offers loyalty, engagement, and customer data solutions that help enterprises improve retention, boost revenue, and enhance consumer experiences across multiple industries.

Capillary Technologies India Ltd has an operating revenue of Rs. 1,141.51 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 143 indicates it belongs to a poor industry group of Computer Sftwr-Enterprse and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Capillary Technologies India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-06 Quarterly Results

Capillary Technologies India F&O

Capillary Technologies India Shareholding Pattern

52.28%
12.78%
0.01%
3.93%
4.99%
26.01%

About Capillary Technologies India

  • NSE Symbol
  • CAPILLARY
  • BSE Symbol
  • 544614
  • Managing Director & CEO
  • Mr. Aneesh Reddy Boddu
  • ISIN
  • INE0ILV01024

Similar Stocks to Capillary Technologies India

Capillary Technologies India FAQs

Capillary Technologies India share price is ₹536 As on 13 February, 2026 | 12:32

The Market Cap of Capillary Technologies India is ₹4252.7 Cr As on 13 February, 2026 | 12:32

The P/E ratio of Capillary Technologies India is As on 13 February, 2026 | 12:32

The PB ratio of Capillary Technologies India is 7.5 As on 13 February, 2026 | 12:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23